AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 39 filers reported holding AGILE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,210,000 | -3.3% | 1,513,975 | 0.0% | 0.21% | -9.2% |
| Q1 2019 | $2,286,000 | +162.2% | 1,513,975 | 0.0% | 0.23% | +105.4% |
| Q4 2018 | $872,000 | +57.1% | 1,513,975 | 0.0% | 0.11% | +98.2% |
| Q3 2018 | $555,000 | -25.2% | 1,513,975 | 0.0% | 0.06% | -41.7% |
| Q2 2018 | $742,000 | -80.9% | 1,513,975 | 0.0% | 0.10% | -82.6% |
| Q1 2018 | $3,891,000 | -4.5% | 1,513,975 | 0.0% | 0.55% | -36.8% |
| Q4 2017 | $4,073,000 | -39.7% | 1,513,975 | 0.0% | 0.87% | -36.1% |
| Q3 2017 | $6,752,000 | +18.9% | 1,513,975 | 0.0% | 1.36% | -4.5% |
| Q2 2017 | $5,677,000 | +17.0% | 1,513,975 | 0.0% | 1.43% | +0.2% |
| Q1 2017 | $4,852,000 | -43.8% | 1,513,975 | 0.0% | 1.43% | -49.8% |
| Q4 2016 | $8,630,000 | -38.8% | 1,513,975 | -25.0% | 2.84% | -35.3% |
| Q3 2016 | $14,099,000 | -8.3% | 2,019,955 | 0.0% | 4.39% | +4.7% |
| Q2 2016 | $15,372,000 | +22.5% | 2,019,955 | 0.0% | 4.20% | +33.4% |
| Q1 2016 | $12,544,000 | – | 2,019,955 | – | 3.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|